← Evidence map

ArticleNature cancer2024

MCL1 inhibitor BRD-810 kills cancer cells while minimizing risk of cardiotoxicity.

PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39261678